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Background: Black ginseng (Ginseng Radix nigra, BG) refers to the ginseng steamed for nine times and
ﬁne roots (hairy roots) of that is called ﬁne black ginseng (FBG). It is known that the content of saponin of
FBG is higher than that of BG. Therefore, in this study, we examined antitumor effects against MCF-7
breast cancer cells to target the FBG extract and its main component, ginsenoside Rg5 (Rg5).
Methods: Action mechanism was determined by MTT assay, cell cycle assay and western blot analysis.
Results: The results fromMTT assay showed that MCF-7 cell proliferation was inhibited by Rg5 treatment
for 24, 48 and 72 h in a dose-dependent manner. Rg5 at different concentrations (0, 25, 50 and 100 mM),
induced cell cycle arrest in G0/G1 phase through regulation of cell cycle-related proteins in MCF-7 cells.
As shown in the results from western blot analysis, Rg5 increased expression of p53, p21WAF1/CIP1 and
p15INK4B and decreased expression of Cyclin D1, Cyclin E2 and CDK4. Expression of apoptosiserelated
proteins including Bax, PARP and Cytochrome c was also regulated by Rg5. These results indicate that Rg5
stimulated cell apoptosis and cell cycle arrest at G0/G1 phase via regulation of cell cycle-associated
proteins in MCF-7 cells.
Conclusion: Rg5 promotes breast cancer cell apoptosis in a multi-path manner with higher potency
compared to 20(S)-ginsenoside Rg3 (Rg3) in MCF-7 (HER2/ER+) and MDA-MB-453 (HER2+/ER) hu-
man breast cancer cell lines, and this suggests that Rg5 might be an effective natural new material in
improving breast cancer.
Copyright  2014, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
Ginseng (Panax ginsengMeyer) is a well characterized medicinal
herb listed in the classic oriental herbal dictionary, Shin-nong-bon-
cho-kyung. Ginseng has a sweet taste, is able to keep the body
warm, and has protective effects on the ﬁve viscera (i.e., heart, lung,
liver, kidney, and spleen) [1]. Ginseng can be classiﬁed by how it is
processed. Red ginseng (RG; Ginseng Radix Rubra) refers to ginseng
that has been steamed once. White ginseng (Ginseng Radix Alba)
refers to dried ginseng. Black ginseng (BG; Ginseng Radix Nigra) is
produced by repeatedly steaming fresh ginseng nine times. The ﬁne
roots (hairy roots or ﬁbrous roots) of fresh ginseng that has been
steamed nine times are called Fine Black ginseng (FBG). There are
more than 30 different ginseng saponins with various physiological
and pharmacological activities [2,3]. Ginsenosides are divided into
two groups: protopanaxadiols and protopanaxatriols.
The root of Panax ginseng reportedly has various biological ef-
fects, including anticarcinogenic effects. One study showed that
ginseng extracts induce apoptosis and decrease telomerase activityersity, Cheongpa-ro 47-gil 100, Yo
).
e Korean Society of Ginseng, Publand cyclooxygenase-2 (COX-2) expression in human leukemia cells
[4]. In addition, ginseng extracts suppress 1,2-dimethylhydrazine-
induced colon carcinogenesis by inhibiting cell proliferation [5].
Until recently, research on anticancer effects of ginseng has
focused on ginsenoside Rg3 (Rg3) and ginsenoside Rh2 (Rh2).
Ginsenoside Rg3 is not present in raw ginseng or White ginseng,
but is synthesized during heating hydrolysis; thus, only a small
amount of Rg3 is present in Red ginseng. Ginsenoside Rg3 has an
anticancer effect by suppressing phorbol ester-induced COX-2
expression and decreasing activation of nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-kB) [6]. Its blood pressure
lowering effects have been identiﬁed in rat aorta through
enhancing endothelium-dependent relaxation [7]. Ginsenoside Rg3
in methanol extraction of heat-processed ginseng has antioxidative
and antitumor effects [8].
Ginsenoside Rh2 is a major active anticancer saponin in ginseng
extracts [9]. Ginsenoside Rh2 treatment modulates the protein
expression level of p21 and cyclin D, and leads to a marked
reduction in the proliferation of MCF-7 human breast cancer cellsungsan-gu, Seoul, 140-742, Korea.
ished by Elsevier. All rights reserved.
J Ginseng Res 2015;39:125e134126[10]. It also provokes apoptosis through activating p53 and
inducing the proapoptotic regulator Bax in colorectal cancer cells
[11]. In addition, Rh2 markedly reduces the viability of breast
cancer cells (MCF-7 and MDA-MB-231) by arresting the G1 phase
cell cycle via p15 INK4B and p27 KIP1-dependent inhibition of cyclin-
dependent kinases [12].
Many studies on BG have been performed because interest in it
has increased recently. The main component of BG is reportedly
Rg5 (Fig. 1) [13]. Studies demonstrate it has diverse physiological
activity such as anti-inﬂammatory effects on lipopolysaccharide-
stimulated BV2 microglial cells [14], protective effects on scopol-
amine-induced memory deﬁcits in mice [15], and inhibitory effects
in a mouse model with oxazolone-induced chronic dermatitis [16].
Rg5 reportedly blocks the cell cycle of SK-HEP-1 cells at the Gl/S
transition phase by downregulating cyclin E-dependent kinase
activity [17].
Breast cancer is a very common cancer in womenworldwide. In
the United States, it is estimated that breast cancer is the leading
cause of all cancers (29%) and the second leading cause of death
(14%) [18]. In Korea, 16,015 new cases of breast cancer were re-
ported in 2011 [19]. Anticancer activity of BG extract in the MCF-1
breast cancer cell line exhibited three-fold cytotoxicity, comparedFig. 1. (A) High-performance liquid chromatography chromatogram of ginsenosides in the bu
the ginsenoside standards: a, Rg1; b, Re; c, Rf; d, Rb1; e, Rg2; f, Rh1; g, Rc; h, Rb2; i, F1; j, Rd;
ginsenosides and (C) the composition of ginsenosides in BuOH fraction of Fine Black ginsewith Red ginseng extract [20]. However, ginseng ﬁne roots contain
a higher content of ginseng saponin than ginseng main roots [2]. In
the present study, we therefore aimed to investigate anti-breast
cancer activity (in the MCF-7 cell line) and the action mechanisms
of FBG ethanol extract (EE), FBG butanol fraction (BF; primarily
containing saponin), and Rg5 as the major saponin.
2. Materials and methods
2.1. Materials
Fine Black ginseng (Panax ginseng Meyer) for experiments was
purchased from Kumsan Town, Chungcheongnam Province, the
Republic of Korea in August 2009. All other chemicals were of an
analytical reagent grade. Distilled water for high-performance
liquid chromatography (HPLC) and acetonitrile were purchased
from J.T. Baker SOLUSORB (Philipsburg, NJ, USA). The standards
were purchased from Chromadex (Santa Ana, CA, USA) and Ambo
Institute (Seoul, South Korea). Proton magnetic resonance, carbon
magnetic resonance, heteronuclear multiple quantum coherence
and heteronuclear multiple bond coherence spectra were
measured with INOVA-500 (500 MHz) (Varian, palo alto, CA, USA).tanol (BuOH) fraction of Fine Black ginseng (FBG), compared with the chromatogram of
k, Rg6; l, F4; m, Rk3; n, Rh4; o, (20S) Rg3; p, (20R) Rg3; q, Rk1; r, Rg5. (B) The content of
ng.
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spectrometry device (JMS-700; Jeol, Seoul, Korea). For the experi-
ments, Rg3 was purchased from Chromadex. Rosewell Park Me-
morial Institute (RPMI 1640) medium (Buffalo, NY, USA), fetal
bovine serum (FBS), trypsin-EDTA, and penicillin/streptomycin
were purchased from Welgene (Daegu, South Korea); and
(3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bro-
mide (MTT) and 3,30-dihexyloxacarbo-cyanine iodide (DiOC6) were
purchased from Sigma-Aldrich (St. Louis, MO, USA). The following
antibodies were used: poly (ADP-ribose) polymerase (PARP), Bid,
DR5, caspase-8, cleaved caspase-7, cleaved caspase-6, p53, b-actin
(Cell signaling, Danvers, MA, USA); cytochrome C (BD Biosciences,
San Jose, CA, USA); and Bcl-2, Bax, and DR4 (Santa Cruz Bio-
technologies, Santa Cruz, CA, USA).2.2. Preparation of ethanol extract and butanol fraction
Fine Black ginseng (10 kg) was selected, dried, and powdered.
Exactly 2 kg of powdered sampleswere reﬂuxed two timeswith 10 L
of 95% ethyl alcohol for 2 h in awater bath. The extractswereﬁltered
through ﬁlter paper (Nylon membrane ﬁlters 7404-004; Whatman,
Dassel, Germany) and concentrated by a vacuum evaporator (yield:
18.35%). Ethyl alcohol extract (150 g) was dissolved in 1500 mL of
water and extracted with 1500 mL of diethyl ether. The aqueous
layer was extracted three times with 1500mL of water-saturated n-
butanol (n-BuOH). The n-BuOH fraction (84.50 g) was evaporated.2.3. HPLC analysis
The ginsenoside composition of the concentrate was analyzed
by HPLC, as suggested by Ko and colleagues [13,21]. The total gin-
senoside content and composition of each sample were analyzed
three times. The 99% pure ginsenoside standards used in this
experiment were purchased from Chromadex and the Ambo
Institute. For the experiment, the Waters 1525 binary HPLC system
(Waters, Milford, MA, USA) and the Eurospher 100-5 C 18 column
(3  250 mm; Knauer, Berlin, Germany) were used. The mobile
phase was a mixture of acetonitrile (HPLC grade) and distilled
water (HPLC grade). The content of acetonitrile was sequentially
increased from 17% to 30% (35min), from 30% to 40% (60min), from
40% to 60% (100 min), from 60% to 80% (110 min), from 80% to 80%
(120 min), from 80% to 100% (125 min), from 100% to 100%
(135 min), and ﬁnally from 100% back to 17% (140 min, lasting for
5 min). The operating temperature was at room temperature and
the ﬂow rate was 0.8 mL/min. The elution proﬁle on theFig. 2. (A) The HMQC (500 MHz, in pyridine) and (B) the fast atomchromatogramwas obtained by using a UV/VIS detector at 203 nm
(Waters 2487 dual l absorbance detector; Waters) (Fig. 1A).
2.4. Isolation and identiﬁcation of ginsenoside Rg5
The n-BuOH fraction (60 g) was chromatographed on a silica gel
column (1 kg) with eluting solvents of CHCl3-MeOH-H2O (70:30:4)
to obtain six subfractions (F1eF5). The F4 fraction (2.59 g) was
further subjected to octadecylsilane (ODS) (C-18) column chro-
matography (500 g, 60% acetonitrile (ACN)) to provide Rg5 (0.19 g)
(Fig. 1B).
In the FAB-MS spectrum of compound I [M-H] peak appeared
at m/z 765. 1H-NMR spectrum (pyridine-d5) showed eight methyl
signals (CH3-18, 30, 29, 19, 28, 27, 26, 21) at d 0.835, 0.979, 1.040,
1.130, 1.313, 1.603, 1.644, 1.840, H-3 and H-23 signals at d 3.288,
d 2.791, On the other hand, proton signal resulting from the binding
to C-3 glucose, and it was conﬁrmed from d 3.937 to d 4.597. And the
H-10 and H-100 signal from the binding to C-3 glucosewas conﬁrmed
in d 4.950 and d 5.400. 13C-NMR spectrum (pyridine-d5) showed C-
1, C-2, C-3, C-4, C-5, C-6, C-7, C-8, C-9, C-10, C-11, C-12, C-13, C-14, C-
15, C-16, C-17, C-18, C-19, C-20, C-21, C-22, C-23, C-24, C-25, C-26, C-
27, C-28, C-29, C-30, 3-Glc C-10, 3-Glc C-20, 3-Glc C-30, 3-Glc C-40, 3-
Glc C-50, 3-Glc C-60, 3-Glc C-100, 3-Glc C-200, 3-Glc C-300, 3-Glc C-400, 3-
Glc C-500, 3-Glc C-600 signals at d 39.76, 28.60, 89.42, 40.75, 56.89,
18.93, 35.84, 40.21, 51.26, 37.51, 32.72, 73.08, 50.94, 51.52, 33.13,
27.25, 51.40, 16.94, 17.09, 140.66, 13.66, 123.82, 27.95, 123.92, 131.74,
26.18, 18.22, 28.60, 16.31, 17.52, 105.62, 83.95, 78.45, 72.15, 78.76,
63.34, 106.55, 77.64, 78.84, 72.12, 78.62, 63.19 (Fig. 2) [22].
2.5. Cell culture and MTT assay
MCF-7 (HER2-/ERþ) and MDA-MB-453 (HER2þ/ERe) human
breast cancer cell lines were maintained using RPMI 1640 medium
supplemented with 10% (vol/vol) FBS (Welgene, Daegu, South Ko-
rea) plus 100 units/mL penicillin and streptomycin in a 5% carbon
dioxide air incubator at 37C. Cell cytotoxicity was measured by
MTT assay. Cells were seeded in 96-well tissue culture plates at the
density of 0.2  104 cells per well with 100 mL medium, and were
allowed to become attached for 24 h. One hundred microliters of
the mediumwith different concentrations of Rg5 (e.g., 0mM, 25mM,
50mM, and 100mM) were added to each well. At indicated times,
30 mL MTT stock solution (3 mg/mL) were added to each well. After
culturing the cells at 37C for 2 h, dimethyl sulfoxide (DMSO) was
added to dissolve the formazan crystals. The absorbance was read
at the wavelength of 540 nm with a microplate reader (EL800,
Biotek Instruments Inc., Winooski, VT, USA).bombardment mass spectroscopy spectrum of ginsenoside Rg5.
J Ginseng Res 2015;39:125e1341282.6. Western blot analysis
After treatment, the pellet of cells was rinsed with ice-cold
phosphate buffered saline (PBS) and lysed in radio-
immunoprecipitation assay buffer (0.1% sodium dodecyl sulfate,
0.5% sodium deoxycholate, 50mM Tris-HCl and 0.1% NP-40, pH 8.0
with 150mM sodium chloride) for 1 h at 4C. The cell lysate was
cleared by centrifugation at 17,000 rpm for 10 min at 4C. Each
supernatant sample was separated by 10% sodium dodecyl sulfatee
polyacrylamide gel electrophoresis and the separated protein was
transferred to polyvinylidene ﬂuoride (PVDF) membranes. After
blocking with 5% nonfat dry milk in TBS-T (25mM Tris and 0.1%Fig. 3. (A and B) Effects of ethanol extraction and (C and D) BF of FBG on cell viability in MD
were seeded in the 96-well plate at 2  103 cells per well and treated as indicated. Cell
bromide (MTT) assay. Statistical signiﬁcance at *p < 0.05 and **p < 0.001, versus the contrTween 20, 137mM sodium chloride) at room temperature (RT) for
2 h, the membranes were incubated with primary antibodies
overnight at 4C and treated with horseradish peroxidase-conju-
gated secondary antibodies for 2 h. The signals were detected with
the ECL Advance Detection Kit (GE Healthcare Bio-Sciences Corp.,
Piscataway, NJ, USA) by LAS-3000 luminescent image analysis.
2.7. Annexin V/ﬂuorescein isothiocyanate/propidium iodide assay
and analysis of surface expression of DR4 and DR5
Apoptosis was evaluated by annexin V/ﬂuorescein isothiocya-
nate/propidium iodide (annexin V-FITC/PI) dual staining. TreatedA-MB-453 [453] (HER2þ/ERe) and MCF-7 (HER2e/ERþ) breast cancer cell lines. Cells
viability was evaluated by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
ol. EE, ethanol extract; BF, butanol fraction; FBG, Fine Black ginseng.
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combination of annexin V/FITC solution and PI solutionwere added
to each tube. The stained cells were incubated at room temperature
for 30 min in the dark. Samples were analyzed by the FACSCanto II
Flow Cytometer (BD Biosciences, San Jose, CA, USA).
Cells were analyzed for their cell surface expression of DR4 and
DR5 by indirect staining with primary mouse anti-human DR4 and
DR5, followed by phycoerythrin (PE)-conjugated goat anti-mouse
immunoglobulin G1 (IgG1). The treated cells were harvested and
washed with PBS containing 1% bovine serum albumin. Cells were
incubated with anti-DR4 or anti-DR5 antibody for 30 min at 4C in
the dark. After incubation, cells were washed twice and reacted
with PE-labeled secondary antibody for 30 min at 4C in the dark.
Isotype-matched nonbinding antibodies (Iso) were the negative
control cells. Samples were measured by ﬂow cytometry.Fig. 4. The effects of the (A and B) ginsenoside Rg3 and (C and D) ginsenoside Rg5 on cell vi
Cells were treated with the indicated concentration of ginsenosides for 24 h, 48 h, and 72 h. C
bromide (MTT) assay. * Indicates a signiﬁcant difference at p < 0.05, versus the control. **2.8. Analysis of cell cycle and microscopic images of DAPI staining
Analysis of the cell cyclewas performed by stainingwith PI. Cells
were seeded into a 100-mm dish, which contained 1 106 cells per
plate. After 24 h, the media were changed to RPMI 1640 medium
supplemented with indicated concentrations of Rg5. After 48 h of
incubation, the cells were trypsinized and washed with ice-cold
PBS, ﬁxed with ice-cold 90% ethanol, and then incubated at 20C
until analysis. For cell cycle analysis, the cells were resuspended in
300 mL of PBS containing 30 mL RNase A solution (10 mg/mL;
Sigma-Aldrich) and 1.5 mL PI solution (1 mg/mL; Molecular Probes).
After incubation at 37C for 30 min, cells were determined using
the FACSCanto II Flow Cytometer (BD Biosciences, San jose, CA,
USA). The cell cycle distribution was analyzed by FlowJo software
(Tree Star, Inc., Ashland, OR, USA).ability in MDA-MB-453 (HER2þ/ER) and MCF-7 (HER2/ERþ) breast cancer cell lines.
ell viability was assessed by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
Indicates a signiﬁcant difference at p < 0.001, versus the control.
J Ginseng Res 2015;39:125e134130Cells were plated at 0.3  106 cells in six-well plates. After
treatment, the cells were ﬁxed in DMSO/methanol (1:4) solution
for 12 h at 4C, stained with 40,6-diamidino-2-phenylindole (DAPI)
for 20 min, and observed by ﬂuorescence microscopy.
2.9. Statistical analysis
Statistical signiﬁcance was performed by Turkey’s multiple
comparison tests (Sigma Plot version 10.0; Systat Software, San
Jose, CA). All experiments were repeated at least three times. Data
were analyzed by one-way analysis of variance (ANOVA), and each
value was presented as the mean  the standard deviation.
3. Results
3.1. Isolation and analysis of ginsenoside Rg5
The yield of ginsenosides from ginseng hairy root (i.e., ﬁne root)
was higher than the yield from the main root [2], and the saponin
content of FBG was higher than that of BG [23]. First of all, the HPLC
results showed Rg5 was the main constituent among the ginse-
nosides in FBG (Fig. 1A). Rg5 was separated from FBG BF using
column chromatography (silica gel, ODS) (Figs. 1B, 1C), and the
chemical structure was conﬁrmed by spectroscopic methods [e.g.,
NMR, mass spectroscopy (MS)] (Fig. 2).
3.2. Cytotoxicity of the FBG extract and its main component,
ginsenoside Rg5
The effects of FBG EE and FBG BF on cell viability were evaluated
in MCF-7 and MDA-MB-453 breast cancer cell lines by MTT assay.
The results showed that EE reduced MCF-7 cell viability after 48 h
of treatment and it decreased cell viability of MDA-MB-453 cellsFig. 5. The effect of ginsenoside Rg5 on cell cycle arrest at the G0/G1 phase. Cells were trea
48 h. The cell cycle was measured by ﬂuorescence-activated cell sorting. The data are represe
p < 0.001, versus the control.after 72 h (Figs. 3A, 3B). Increased cell viability was detected in
MCF-7 cells when it was treated with 50 mg/mL (at 24 h, 48 h, and
72 h) and 100 mg/mL (24 h) of BF, but at higher concentrations
(150 mg/mL and 200 mg/mL) the cell viability was decreased in a
dose-dependent manner (Figs. 3C, 3D). As Figs. 4C and 4D show,
Rg5, the main component of FBG, exerted signiﬁcant cytotoxicity in
a dose- and time-dependent manner. The cytotoxic effect of 20(S)-
Rg3 in MCF-7 cells unexpectedly showed no signiﬁcant difference.
These results were consistent when Rg3 was treated in MDA-MB-
453 cells (Figs. 4A, 4B).
3.3. Effects of ginsenoside Rg5 on cell cycle arrest
The results from ﬂow cytometric analysis [i.e., ﬂuorescence-
activated cell sorting (FACS)] indicated that Rg5 signiﬁcantly
induced cell cycle arrest (Figs. 5A, 5B). This was further conﬁrmed
by the cell cycle assay with the data representing suppressed cell
proliferation in MCF-7 cells after Rg5 treatment. Rg5 increased the
number of cells in the G0/G1 phase and decreased the number of
cells in the S phase. Based on these results, Rg5 may induce cell
cycle arrest at the G0/G1 phase. Protein expression of cyclin D1,
cyclin E2 and CDK4 was decreased, whereas the expression of
p15INK4B, p53 and p21WAF1/CIP1 was increased (Figs. 6A, 6B).
3.4. Effects of ginsenoside Rg5 on apoptosis-related proteins
As Fig. 7A shows, treatment with Rg5 induced caspase-8 and
caspase-9, caspase-7, caspase-6. The full-length Bid consequently
disappeared in a dose-dependent manner. Poly (ADP-ribose) po-
lymerase (PARP) cleavage was detected in Rg5-treated MCF-7 cells,
which indicated that Rg5 reduced cell viability by inducing
apoptosis. Promotion of mitochondria-mediated intrinsic apoptotic
pathway by Rg5 was evidenced by Bax/Bcl-2 dysregulation,ted with dimethyl sulfoxide (0.01%) or ginsenoside Rg5 (25mM, 50mM, and 100mM) for
ntative of at least three independent experiments. * Indicates a signiﬁcant difference at
Fig. 6. Effects of ginsenoside Rg5 on G1-related proteins in MCF-7 cells. Cells were treated with DMSO (0.01%) or ginsenoside Rg5 (25, 50 and 100 mM) for 48 h. Protein expressions
were determined using western blotting. *p < 0.05, **p < 0.001 versus control are signiﬁcant different.
S.-J. Kim and A.K. Kim / Anti-breast cancer activity of ginsenoside Rg5 131activation of caspase-9, and release of cytochrome C (Fig. 7A).
Apoptosis was evaluated by annexin V/FITC/PI dual staining. After
48 h, Rg5 signiﬁcantly increased apoptosis at 25mM and 50mM and
reduced apoptotic cells at 100mM, whereas necrotic cells were
increased (Fig. 7B). The increased expression of DR4 and DR5 on the
cell surface was obvious when cells were treated at the 100mM
concentration of Rg5 (Fig. 8A). Activation of p38 mitogen-activated
protein kinases (MAPKs) is necessary for apoptosis induced byFig. 7. Effects of ginsenoside Rg5 on MCF-7 cell apoptosis. (A) Effects of ginsenoside Rg5 o
ginsenoside Rg5 (25, 50 and 100 mM) for 48 h. (B) Apoptosis was evaluated by Annexin V-F
*p < 0.05, **p < 0.001.exposure to ultraviolet radiation, cytokines, chemotherapy, cer-
amide, and serum deprivation [24]. When cells were treated with
Rg5 (50mM and 100mM), p38 MAPKs were activated with the gen-
eration of reactive oxygen species (data not shown) (Fig. 8C). Sur-
vivin, an inhibitor of apoptotic proteins, is highly expressed in most
types of cancer and is a regulator of mitosis; survivin-targeting
cancer treatment is validated with great efﬁcacy and no serious
toxicity [25]. The expression of survivin was suppressed at highn apoptosis-related proteins in MCF-7 cells. Cells were treated with DMSO (0.01%) or
ITC/PI dual staining. The value represents mean  SD (n ¼ 3). Statistical signiﬁcance at
Fig. 8. (A) Effects of ginsenoside Rg5 on DR4 and DR5 expression in MCF-7 cells. The cells were incubated for 48 h with 100 mg/mL ginsenoside Rg5. DR4 and DR5 surface ex-
pressions were analyzed by FACS using PE-conjugated anti-DR4 and anti-DR5 antibodies. Isotype-matched nonbinding antibodies (Iso) were used as control for unspeciﬁc binding.
(B) The protein levels of DR4 and DR5 were evaluated by western blotting. (CeD) The protein levels of p-p38/p38 and survivinwere analyzed by western blotting. The bar represents
the mean  SD (n ¼ 3). *p < 0.05, **p < 0.001 versus control are signiﬁcantly different.
J Ginseng Res 2015;39:125e134132concentrations of Rg5 (Fig. 8D). Apoptotic cells were visualized
with DAPI as ﬂuorescent probes. When cells were incubated for
48 h with Rg5 at indicated concentrations (i.e., 0mM, 50mM, and
100mM), the cells displayed the typical apoptosis morphology such
as fragmented and condensed nuclei with cellular shrinkage
(Fig. 9B). Cells treated with Rg5 at the 100mM concentration
showed a necrosis-like morphology (Fig. 9C).4. Discussion
Red ginseng is fresh ginseng that is dry-steamed once using
water vapor. Black ginseng refers to ginseng that is steamed nineFig. 9. Effects of ginsenoside Rg5 on MCF-7 cells (A, B, C) and MDA-MB-453 cells (D, E, F) m
morphology was investigated under the ﬂuorescence microscope. A, D: control (DMSO 0.01times. Fine Black ginseng refers to the ﬁne roots (i.e., hairy roots) of
BG steamed nine times.
As Fig. 1C shows, FBG BF contained more than 40% of the total
saponins. The amount of total saponin in the FBG BF was 17 times
higher than in BG EE, and was 26 times higher than in RG EE [26].
Fine Black ginseng contained the highest content of Rg5 (9.831%)
(Fig. 1C). The amount of Rg5 in FBG BF was 34 times higher than in
BG EE, and was 110 times higher than in RG EE [26]. Rg5, the main
component of FBG BF, was isolated using column (silica gel, ODS)
chromatography, and the chemical structure was conﬁrmed by
spectroscopic analysis (i.e., NMR, MS) (Fig. 2).
The difference in chemical structure between Rg5 and Rg3 is the
polar hydroxyl group of C-20 in Rg3. When C-20 is inducedorphology. Cells were treated with 50 and 100 mM ginsenoside Rg5 for 48 h and cell
%), B, E: ginsenoside Rg5 50 mM, C, F: ginsenoside Rg5 100 mM.
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steam, Rg3 is converted to Rk1 and Rg5. Dehydration of the C-20 of
the ginsenoside structure increases its bioactivity [27]. Rg5 (i.e., Rg3
that has been dehydrated at C-20) reportedly has cytostatic activity
of human hepatoma SK-HEP-1 cells that is approximately four
times stronger than that of Rg3 [17].
Therefore, the purpose of this study was to elucidate anti-breast
cancer activity of FBG extract and Rg5 in MCF-7 cells. The FBG
extract and Rg5 showed signiﬁcant cytotoxic activity. In previous
studies, the BG extract in comparison to RG extract exhibited
stronger cytotoxic activity in vitro on the MCF-1 breast cancer cell
line, HT-1080 ﬁbrosarcoma cell line and Hepa1C1C7 murine hep-
atoma cell line [20].
The anticancer properties of Rg3 are associated with inducing
apoptosis [28], regulating cell cycle [29], blocking angiogenesis
[30], and inhibiting proliferation. Rg3 exhibits anticancer activity in
various cell lines such as human hepatocellular carcinoma cells
(Hep3B) [31], the PC-3M prostate cancer cell line [32], VX2 liver
tumors [33], and the U87MG human glioblastoma cell line [28].
However, the cytotoxic effect of 20(S)-Rg3 in MCF-7 cells showed
no signiﬁcant difference, and the results were consistent when
MDA-MB-453 cells were treated by Rg3 (Figs. 4A, 4B).
Cell cycle arrest and western blot analysis were performed to
determine the mechanism of action for the anticancer effects of
Rg5. As a result, Rg5 induced signiﬁcant G0/G1 cell cycle arrest. The
results of western blot analysis showed increased Bax (i.e., proap-
optotic regulator), caspase-6 and caspase-7 (i.e., effector caspases),
DR4, and DR5. These results were evident even when Rh2 induced
apoptosis in colorectal cancer cells through activation of p53 [34].
The tumor suppressor p53 induces cell self-destruction through the
endogenous mitochondrial pathway and exogenous death receptor
pathway. This is called p53-dependent apoptosis (i.e., p53-induced
apoptosis). In particular, p53-dependent apoptosis is used to induce
the expression of proapoptotic members. Bax also is expressed by
the activation of p53 [35,36]. When the cells undergo DNA damage,
p53 stops the cell cycle through p21 or it induces apoptosis. In
response to cellular stress or DNA damage, p53 is stabilized by post-
transcriptional modiﬁcations and the level of p53 increases [37].
Stabilization and activation of p53 is responsible for cellular anti-
proliferative mechanisms such as apoptosis, growth arrest, and cell
senescence [38]. This study conﬁrmed the inﬂuence of Rg5 on the
activity of Bax and p53.
The data showed that the expression of DR4 and DR5 was
upregulated by Rg5 in a dose-dependent manner. The tumor ne-
crosis factor-related apoptosis-inducing ligand (TRAIL) is a prom-
ising agent for cancer treatment because it selectively induces
apoptosis in various cancer cells, but not in normal cells [39]. Many
tumor cells are resistant to TRAIL-induced apoptosis. Therefore, it is
important to develop combination therapies to overcome this
resistance [40]. Rg5 did not increase TRAIL-induced apoptosis,
which suggests that Rg5 does not increase the susceptibility of
TRAIL-resistant MCF-7 cells. Therefore, Rg5 was unsuitable for
combination therapy.
To examine whether Rg5 reduced cell viability via apoptosis,
cells were analyzed by using annexin V-FITC/PI staining assay. Rg5
at 0mM, 25mM, and 50mM concentrations increased apoptosis in a
dose-dependent manner. However, at 100mM concentration of Rg5,
apoptotic cells were reduced, whereas necrotic cells were
increased. There are many natural substances similar to this situ-
ation. Procyanidin, a polyphenol compound with strong bioactivity
and pharmacologic activity, exists widely in grape seeds, hawthorn,
and pine bark. Procyanidin induces apoptosis and necrosis of
prostate cancer cell line PC-3 in a mitochondrion-dependent
manner. With extended procyanidin treatment, the apoptosis rate
decreased, whereas the necrosis rate increased. This change wasassociatedwith cytotoxic properties that were related to alterations
in cell membrane properties [41,42].
Rg5 induces cancer cell apoptosis in a multipath mechanism,
and is therefore a promising candidate for antitumor drug devel-
opment. The antitumor role of Rg5 would be useful in therapeutic
approaches (e.g., in combination therapy with other cancer
chemotherapy drugs). In this study, we elucidated the effects of Rg5
in MCF-7 and MDA-MB-453 human breast cancer cell lines, which
demonstrated that Rg5 may be an effective chemotherapeutic
agent for breast cancer. However, further studies are needed to
identify the precise mechanism of Rg5. There is also a need for in
vivo experiments to conﬁrm the anticancer activity of Rg5.
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